This study shows that JHMs (especially TJ-9 and TJ-48) significantly improved the serum ALT levels and liver histology, including the degree of fibrosis, in an animal model of NASH. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.